Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-04

Clinical Trial Update: Ex Vivo Effect of Surfactant Protein D on Pulmonary Immune Cells Derived From Bronchoalveolar Lavage After Segmental Allergen Challenge in Patients With Asthma [NA]

View source ↗

Summary

Ex vivo study evaluating the effect of surfactant protein D on pulmonary immune cells derived from bronchoalveolar lavage after segmental allergen challenge in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Surfactant Protein D (surfactant protein D)

Snippet

Sponsor: Fraunhofer-Institute of Toxicology and Experimental Medicine | Conditions: Asthma | NA | Status: COMPLETED